Related Experiment Video
Updated: Jul 8, 2025
07:54
Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
Published on: April 13, 2017
9.8K
Microglial APOE4: more is less and less is more
Ghazaleh Eskandari-Sedighi1,2, Mathew Blurton-Jones3,4,5
1Institute for Memory Impairments and Neurological Disorders, University of California Irvine, Irvine, CA, 92697, USA.
Molecular Neurodegeneration
|December 20, 2023
Summary
Apolipoprotein E (APOE) significantly impacts Alzheimer's disease (AD) risk. New studies clarify how APOE in microglia influences AD, offering crucial insights into disease mechanisms.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Apolipoprotein E (APOE) is the primary genetic risk factor for late-onset Alzheimer's disease (AD).
- The specific role of APOE in microglial function concerning AD pathogenesis has been poorly understood.
Discussion:
- Two recent studies in Nature Immunology utilized complementary genetic approaches (gain-of-function and loss-of-function).
- These studies investigated the impact of microglial APOE on Alzheimer's disease progression.
Key Insights:
- Microglial APOE plays a critical role in Alzheimer's disease pathogenesis.
- Understanding cell-specific APOE functions is essential for dissecting AD mechanisms.
Outlook:
- Further research into microglial APOE function may reveal novel therapeutic targets for AD.
- These findings pave the way for developing targeted interventions against APOE-mediated microglial dysfunction in Alzheimer's.
